Your browser doesn't support javascript.
loading
The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.
Liu, Haiyan; Lan, Xiaofeng; Wang, Chengyu; Zhang, Fan; Fu, Ling; Li, Weicheng; Ye, Yanxiang; Hu, Zhibo; Chao, Ziyuan; Ning, Yuping; Zhou, Yanling.
Afiliação
  • Liu H; Guangdong Engineering Technology Research Center for Translational Medicine of Metal Disorders, Guangzhou, China.
  • Lan X; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
  • Wang C; Guangdong Engineering Technology Research Center for Translational Medicine of Metal Disorders, Guangzhou, China.
  • Zhang F; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
  • Fu L; Guangdong Engineering Technology Research Center for Translational Medicine of Metal Disorders, Guangzhou, China.
  • Li W; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
  • Ye Y; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
  • Hu Z; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Chao Z; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
  • Ning Y; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Zhou Y; Guangdong Engineering Technology Research Center for Translational Medicine of Metal Disorders, Guangzhou, China.
BMC Psychiatry ; 22(1): 744, 2022 11 30.
Article em En | MEDLINE | ID: mdl-36451150

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suicídio / Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suicídio / Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido